Solcoseryl versus Low Molecular Weighte Heparin for Intrauterine Fetal Growth Restriction
Samar M. Abd El-Razek, Mohammed M. Elnamory, Mona K. Omar & Hesham M. Eltokhy · Journal of Advances in Medicine and Medical Research · 2021
Background: FETAL Growth Restriction (FGR) is a problem where the fetus fails to attain its normal growth potential and this affects nearly about 8% of all pregnancies Solcoseryl is a protein-free and antigen-free haemodialysate derived from calf blood. It is thought to activate...
Open access
Research Article
10.9734/jammr/2021/v33i1931097